Fox Run Management’s Evolent Health EVH Stock Holding History

Fox Run Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,778	Closed	-$99.6K	–	1007
2025 Q3	$99.6K	Buy	+11,778	New	+$114K	0.02%	862
2025 Q2	–	Sell	-12,919	Closed	-$122K	–	971
2025 Q1	$122K	Buy	+12,919	New	+$130K	0.02%	852
2023 Q1	–	Sell	-14,046	Closed	-$394K	–	742
2022 Q4	$394K	Buy	14,046 +1,473	+12%	+$42.2K	0.16%	243
2022 Q3	$452K	Buy	+12,573	New	+$443K	0.18%	208
2019 Q3	–	Sell	-26,891	Closed	-$214K	–	422
2019 Q2	$214K	Buy	26,891 +16,569	+161%	+$196K	0.14%	347
2019 Q1	$130K	Buy	+10,322	New	+$163K	0.07%	413
2018 Q3	–	Sell	-11,666	Closed	-$246K	–	647
2018 Q2	$246K	Buy	+11,666	New	+$221K	0.08%	509
2018 Q1	–	Sell	-14,250	Closed	-$175K	–	777
2017 Q4	$175K	Buy	+14,250	New	+$201K	0.05%	592
2017 Q3	–	Sell	-14,300	Closed	-$363K	–	729
2017 Q2	$363K	Buy	+14,300	New	+$344K	0.13%	340

Other funds holding EVH

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fox Run Management's EVH Position: Q4 2025 in Review

Fox Run Management sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 11,778 shares — an estimated $99.6K sold.

Fox Run Management first reported a position in EVH in Q2 2017 and held it in 9 quarters. The position peaked at $452K in Q3 2022. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

Fox Run Management reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
Fox Run Management sold 11,778 Evolent Health shares in Q4 2025, an estimated $99.6K.
Fox Run Management first reported a position in Evolent Health in Q2 2017 and held it in 9 quarters.
Fox Run Management's Evolent Health position peaked at $452K in Q3 2022.
215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on Fox Run Management's 13F filing for Q4 2025, filed 11 Feb 2026.